Investigating a Caddo Mound Site in the Ouachita River Valley

Archeologists from the Natural Resources Conservation Service and Arkansas Archeological Survey employed multiple techniques to investigate a newly recorded mound site (3DA673) in the Ouachita River valley in southern Arkansas. Topographic mapping documented a large two-stage mound. Geophysical surveying around the mound revealed anomalies in the gradiometry and resistance data, and soil coring detailed floodplain soils. A test unit was excavated in a large circular anomaly that corresponded to a low topographic rise north of the main mound. While very few artifacts were found, a burned zone and a post mold feature suggest the anomaly was a burned structure covered with fill, and show the potential for buried cultural deposits at the site. Based on the 2010–2011 investigations, 3DA673 and the neighboring site 3DA403 represent the archeological residues of a Middle to Late Caddo period community (ca. A.D. 1400s)

Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence

Background: Bezlotoxumab is a human monoclonal antibody against Clostridium difficile toxin B indicated to prevent C. difficile infection (CDI) recurrence (rCDI) in adults at high risk for rCDI. This post hoc analysis of pooled monocolonal antibodies for C.difficile therapy (MODIFY) I/II data assessed bezlotoxumab efficacy in participants with characteristics associated with increased risk for rCDI. Methods: The analysis population was the modified intent-to-treat population who received bezlotoxumab or placebo (n = 1554) by risk factors for rCDI that were prespecified in the statistical analysis plan: age ≥65 years, history of CDI, compromised immunity, severe CDI, and ribotype 027/078/244. The proportion of participants with rCDI in 12 weeks, fecal microbiota transplant procedures, 30-day all cause and CDI-associated hospital readmissions, and mortality at 30 and 90 days after randomization were presented. Results: The majority of enrolled participants (75.6%) had ≥1 risk factor; these participants were older and a higher proportion had comorbidities compared with participants with no risk factors. The proportion of placebo participants who experienced rCDI exceeded 30% for each risk factor compared with 20.9% among those without a risk factor, and the rCDI rate increased with the number of risk factors (1 risk factor: 31.3%; ≥3 risk factors: 46.1%). Bezlotoxumab reduced rCDI, fecal microbiota transplants, and CDI-associated 30-day readmissions in participants with risk factors for rCDI. Conclusions: The risk factors prespecified in the MODIFY statistical analysis plan are appropriate to identify patients at high risk for rCDI. While participants with ≥3 risk factors had the greatest reduction of rCDI with bezlotoxumab, those with 1 or 2 risk factors may also benefit. Clinical Trials Registration: NCT01241552 (MODIFY I) and NCT01513239 (MODIFY II)

Foreward and Preface to Courier, Volume XXVI, Number 2, Fall 1991

IT WAS THE experiences of World War II that made me, along with others, realize that if peace were to be maintained we would need a more enlightened citizenry, more people qualified in the occupations and professions, and more understanding of the international scene. During the war it had become apparent that adults, under great pressure and in short periods of time, could learn how to rivet (Rosie the Riveter!), how to speak new languages, how to operate the machines of war, and how to become leaders. Clearly, adult men and women could learn \u27new tricks\u27. They could acquire the knowledge and skills appropriate to peacetime. To help make this possible, I committed myself to the development of the field of adult education

Soil Leachate Responses During 10 Years of Induced Whole-Watershed Acidification

Soil solution was collected from zero-tension lysimeters for 10 yr on two small central Appalachian watersheds in West Virginia, U.S.A. Ammonium sulfate fertilizer was applied to one catchment 3 times per year during each year. The other watershed was used as a reference to account for ambient baseline conditions. Ca and Mg concentrations collected below the A- and B-horizons of the treated watershed increased and then decreased over time as a result of the treatment. By contrast, Ca and Mg concentrations in the C-horizon continued to increase throughout the study period

Recovery of Central Appalachian Forested Watersheds Comparison of

The Fernow Experimental Forest (FEF) was established to conduct research in forest and watershed management in the central Appalachians. The 1868-ha FEF, located south of Parsons, West Virginia, is administered by the Northern Research Station of the USDA Forest Service and provides a valuable point o

Fertilization and Tree Species Influence on Stable Aggregates in Forest Soil

Abstract: Background and objectives: aggregation and structure play key roles in the water-holding capacity and stability of soils and are important for the physical protection and storage of soil carbon (C). Forest soils are an important sink of ecosystem C, though the capacity to store C may be disrupted by the elevated atmospheric deposition of nitrogen (N) and sulfur (S) compounds by dispersion of soil aggregates via acidification or altered microbial activity. Furthermore, dominant tree species and the lability of litter they produce can influence aggregation processes. Materials and methods: we measured water-stable aggregate size distribution and aggregate-associated organic matter (OM) content in soils from two watersheds and beneath four hardwood species at the USDA Forest Service Fernow Experimental Forest in West Virginia, USA, where one watershed has received (NH4)2SO4 fertilizer since 1989 and one is a reference/control of similar stand age. Bulk soil OM, pH, and permanganate oxidizable carbon (POXC) were also measured. Research highlights: fertilized soil exhibited decreased macro-aggregate formation and a greater proportion of smaller micro-aggregates or unassociated clay minerals, particularly in the B-horizon. This shift in aggregation to soil more dominated by the smallest (\u3c53 μm) fraction is associated with both acidification (soil pH) and increased microbially processed C (POXC) in fertilized soil. Intra-aggregate OM was also depleted in the fertilized soil (52% less OM in the 53–2000 μm fractions), most strongly in subsurface B-horizon soil. We also document that tree species can influence soil aggregation, as soil beneath species with more labile litter contained more OM in the micro-aggregate size class (\u3c250 μm), especially in the fertilized watershed, while species with more recalcitrant litter promoted more OM in the macro- aggregate size classes (500–2000 μm) in the reference watershed. Conclusions: long-term fertilization, and likely historic atmospheric deposition, of forest soils has weakened macro-aggregation formation, with implications for soil stability, hydrology, and storage of belowground C

Reaching the Unreachable: Barriers of the Poorest to Accessing NGO Healthcare Services in Bangladesh

The NGO Service Delivery Program (NSDP), a USAID-funded programme, is the largest NGO programme in Bangladesh. Its strategic flagship activity is the essential services package through which healthcare services are administered by NGOs in Bangladesh. The overall goal of the NSDP is to increase access to essential healthcare services by communities, especially the poor. Recognizing that the poorest in the community often have no access to essential healthcare services due to various barriers, a study was conducted to identify what the real barriers to access by the poor are. This included investigations to further understand the perceptions of the poor of real or imagined barriers to accessing healthcare; ways for healthcare centres to maximize services to the poor; how healthcare providers can maximize service-use; inter-personal communication between healthcare providers and those seeking healthcare among the poor; and ways to improve the capacity of service providers to reach the poorest segment of the community. The study, carried out in two phases, included 24 static and satellite clinics within the catchment areas of eight NGOs under the NSDP in Bangladesh, during June-September 2003. Participatory urban and rural appraisal techniques, focus-group discussions, and in-depth interviews were employed as research methods in the study. The target populations in the study included males and females, service-users and non-users, and special groups, such as fishermen, sex workers, potters, Bedes (river gypsies), and lower-caste people—all combined representing a heterogeneous community. The following four major categories of barriers emerged as roadblocks to accessing quality healthcare for the poor: (a) low income to be able to afford healthcare, (b) lack of awareness of the kind of healthcare services available, (c) deficiencies and inconsistencies in the quality of services, and (d) lack of close proximity to the healthcare facility. Those interviewed perceived their access problems to be: (a) a limited range of NGO services available as they felt what are available do not meet their demands; (b) a high service-charge for the healthcare services they sought; (c) higher prices of drugs at the facility compared to the market place; (d) a belief that the NGO clinics are primarily to serve the rich people, (e) lack of experienced doctors at the centres; and (f) the perception that the facility and its services were more oriented to women and children, but not to males. Others responded that they should be allowed to get treatment with credit and, if needed, payment should be waived for some due to their poverty level. While the results of the study revealed many perceptions of barriers to healthcare services by the poor, the feedback provided by the study indicates how important it is to learn from the poorest segment of society. This will assist healthcare providers and the healthcare system itself to become more sensitized to the needs and problems faced by this segment of the society and to make recommendations to remove barriers and improvement of access. Treatment with credit and waived payment for the poorest were also recommended as affordable alternative private healthcare services for the poor

Acute Ethanol Administration Rapidly Increases Phosphorylation of Conventional Protein Kinase C in Specific Mammalian Brain Regions in Vivo

Background Protein kinase C (PKC) is a family of isoenzymes that regulate a variety of functions in the central nervous system including neurotransmitter release, ion channel activity, and cell differentiation. Growing evidence suggests that specific isoforms of PKC influence a variety of behavioral, biochemical, and physiological effects of ethanol in mammals. The purpose of this study was to determine whether acute ethanol exposure alters phosphorylation of conventional PKC isoforms at a threonine 674 (p-cPKC) site in the hydrophobic domain of the kinase, which is required for its catalytic activity. Methods Male rats were administered a dose range of ethanol (0, 0.5, 1, or 2 g/kg, intragastric) and brain tissue was removed 10 minutes later for evaluation of changes in p-cPKC expression using immunohistochemistry and Western blot methods. Results Immunohistochemical data show that the highest dose of ethanol (2 g/kg) rapidly increases p-cPKC immunoreactivity specifically in the nucleus accumbens (core and shell), lateral septum, and hippocampus (CA3 and dentate gyrus). Western blot analysis further showed that ethanol (2 g/kg) increased p-cPKC expression in the P2 membrane fraction of tissue from the nucleus accumbens and hippocampus. Although p-cPKC was expressed in numerous other brain regions, including the caudate nucleus, amygdala, and cortex, no changes were observed in response to acute ethanol. Total PKC? immunoreactivity was surveyed throughout the brain and showed no change following acute ethanol injection

Efficacy of bezlotoxumab in participants receiving metronidazole, vancomycin, or fidaxomicin for treatment of Clostridioides (Clostridium) difficile infection

Background: In phase 3 MODIFY I/II trials, bezlotoxumab significantly reduced recurrence of Methods: In MODIFY I/II (NCT01241552/NCT01513239), participants received a single infusion of bezlotoxumab (10 mg/kg) or placebo during anti-CDI treatment. Using pooled data from MODIFY I/II, initial clinical cure (ICC) and rCDI were assessed in metronidazole-, vancomycin-, and fidaxomicin-treated subgroups. Results: Of 1554 participants in MODIFY I/II, 753 (48.5%) received metronidazole, 745 (47.9%) vancomycin, and 56 (3.6%) fidaxomicin. Fewer participants receiving metronidazole had a prior CDI episode in the previous 6 months (12.9%) or ≥1 risk factor for rCDI (66.0%) vs participants receiving vancomycin (41.2% and 83.6%, respectively) and fidaxomicin (55.4% and 89.3%, respectively). ICC rates were similar in the bezlotoxumab (metronidazole, 81.0%; vancomycin, 78.5%; fidaxomicin, 86.7%) and placebo groups (metronidazole, 81.3%; vancomycin, 79.6%; fidaxomicin, 76.9%). In placebo-treated participants, the rCDI was lower in the metronidazole subgroup vs the vancomycin and fidaxomicin subgroups (metronidazole, 28.0%; vancomycin, 38.4%; fidaxomicin, 35.0%). When analyzed by subsets based on history of CDI, rCDI rates were similar in the metronidazole and vancomycin groups. rCDI rates were lower in all antibiotic subgroups for bezlotoxumab vs placebo (metronidazole: rate difference [RD], -9.7%; 95% confidence interval [CI], -16.4% to -3.1%; vancomycin: RD, -15.4%; 95% CI, -22.7% to -8.0%; fidaxomicin: RD, -11.9%; 95% CI, -38.1% to 14.3%). Conclusion: Bezlotoxumab reduces rCDI vs placebo in participants receiving metronidazole and vancomycin, with a similar effect size in participants receiving fidaxomicin

The Effect of 17beta Estradiol on Glut1 Expression In The Right Ventricle Of Rats With Severe Pulmonary Hypertension

poster abstractPulmonary hypertension (PH) is a devastating disease that is characterized by a rise of blood pressure in the blood vessels of the lung. This puts significant strain on the right ventricle (RV) of the heart. If untreated, PH can lead to right heart failure and death. One of the hallmarks of right heart failure in PH is the development of cytoplasmic glycolysis in the cardiac muscle cells (myocytes) of the RV. This describes a compensatory process where glucose uptake into the mitochondria is inhibited, thereby leading to its conversion to lactate in the cytoplasm. Importantly, cytoplasmic glycolysis is associated with an increase in a protein called glucose transporter 1 (Glut 1). 17beta estradiol (E2) can ameliorate experimental PH, but its effects on RV glut 1 expression are not yet known. The aim of this project is to determine the RV expression of Glut 1 in a rat model of severe PH, and to investigate whether this is decreased by E2 treatment. We assessed Glut 1 via immunofluorescence staining in cryosections of RV tissue from control rats, untreated PH rats, and E2-treated PH rats. Cell nuclei were stained with DAPI (Diamidinophenyl-indole), cell membranes were stained with WGA (wheat germ agglutinin), and Glut1 was stained with a Glut1 antibody conjugated to a red immunofluorescent dye. Nuclei are stained blue; cell membranes are stained green. Glut 1 quantification occurs via visual inspection and determination of red staining via specific software (Metamorph). We were able to successfully establish the protocol for Glut1 staining. In pilot experiments, there was little Glut1 staining present in normal RVs, but we detected up-regulation of Glut 1 in the RV of animals with PH. Whether this is affected by E2 is currently under investigation